HIF1A and hepatocellular carcinoma: Collectively, our findings uncover a novel m6A‐circIST1‐miR‐140‐3p/miR‐182‐HIF‐1α regulatory axis that underlies metabolic reprogramming in HCC, positioning circIST1 as a promising therapeutic target for HCC metabolic intervention.